乌干达古卢HIV感染与非HIV感染母亲所生婴儿在首剂乙肝疫苗前发生乙肝早期传播罕见
在乌干达古卢招募612对母婴,婴儿至少6周龄、来接种首剂乙肝疫苗。母亲HBsAg阳性率8.7%,抗-HBc-IgG阳性率61.5%;HBsAg阳性母亲中HBeAg阳性18.9%,HBV DNA中位数5.7 log IU/mL。所有婴儿HBsAg和HBV DNA均阴性,垂直传播似不构成当地高流行的重要来源。
要点
- 612名母亲中53名(8.7%)HBsAg阳性,339名(61.5%)抗-HBc-IgG阳性。
- HBsAg阳性母亲中10名(18.9%)HBeAg阳性,HBV DNA中位数5.7 log(IQR 4.6-7.0)IU/mL。
- 所有婴儿在首剂乙肝疫苗时及末次免疫访视时HBsAg或HBV DNA均未呈阳性。
核心结论
- 垂直传播似乎并未显著导致乌干达北部乙肝高地方性流行。
- 乌干达现行在婴儿6周龄时接种首剂乙肝疫苗的做法可能足以控制乙肝传播。
研究设计与样本
- 在乌干达古卢招募至少6周龄、前来接受产后保健和首剂乙肝疫苗接种的母亲及其婴儿。
- 记录社会人口学和乙肝传播危险因素,检测母亲抗-HBc-IgG和HBsAg,HBsAg阳性血清检测HBeAg和HBV DNA。
- 婴儿在就诊时和末次免疫访视时检测HBsAg,部分HBsAg阴性婴儿检测HBV DNA。
- 新发HBV感染定义为HBsAg或HBV DNA检测阳性。
主要发现
- 共招募612名母亲,年龄中位数23岁(IQR 20-28)。
- 53名(8.7%)母亲HBsAg阳性,339名(61.5%)抗-HBc-IgG阳性。
- HBsAg阳性母亲中10名(18.9%)HBeAg阳性;HBV感染母亲HBV DNA中位数5.7 log(IQR 4.6-7.0)IU/mL,9名(17.6%)≥10^5 IU/mL。
- 80名(13.3%)母亲HIV感染,其中9名(11.5%)合并HBV感染。
- 没有婴儿检测HBsAg或HBV DNA阳性。
临床怎么用
- 作者认为,乌干达现行在婴儿6周龄时接种首剂乙肝疫苗的做法可能足以控制乙肝传播。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis B (HBV) in sub-Saharan Africa is believed to be horizontally acquired. However, because of the high HBV prevalence in northern Uganda, no hepatitis B vaccination at birth and no access to HBV immunoglobulin, we hypothesize that vertical transmission also could also play an important role. We therefore investigated the incidence of HBV among babies presenting for their first HBV vaccine dose in Gulu, Uganda. METHODS: We recruited mothers and their babies (at least 6-week old) presenting for their postnatal care and first HBV vaccine dose respectively. Socio-demographic and risk factors for HBV transmission were recorded. Mothers were tested for Hepatitis B core antibody (anti-HBc-IgG) and hepatitis B surface antigen (HBsAg). HBsAg-positive sera were tested for hepatitis B e antigen (HBeAg) and HBV viral load (HBVDNA). Babies were tested for HBsAg at presentation and at the last immunization visit. A sample of HBsAg-negative babies were tested for HBVDNA. Incident HBV infection was defined by either a positive HBsAg or HBVDNA test. Chi-square or fisher's exact tests were utilized to investigate associations and t-tests or Wilcoxon rank-sum test for continuous differences. RESULTS: We recruited 612 mothers, median age 23years (IQR 20-28). 53 (8.7%) were HBsAg-positive and 339 (61.5%) were anti-HBc-IgG-positive. Ten (18.9%) of the HBsAg-positive mothers were HBeAg-positive. Median HBVDNA levels of HBV-infected mothers was 5.7log (IQR 4.6-7.0) IU/mL with 9 (17.6%) having levels≥105IU/mL. Eighty (13.3%) mothers were HIV-infected of whom 9 (11.5%) were co-infected with HBV. No baby tested HBsAg or HBVDNA positive. CONCLUSION: Vertical transmission does not seem to contribute substantially to the high HBV endemicity in northern Uganda. The current practice of administering the first HBV vaccine to babies in Uganda at six weeks of age may be adequate in control of HBV transmission.
引用
- Seremba E, Van Geertruyden JP, Ssenyonga R, et al. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda. Vaccine. 2017. PMID: 28434689. doi:10.1016/j.vaccine.2017.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。